| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jan 25 | XERS Xeris Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 3.56 | 25,842 | 92.00 k | 320,446 |
| 31 Jan 25 | XERS Xeris Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 3.56 | 15,476 | 55.09 k | 346,288 |
| 3 Jan 25 | XERS Xeris Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 3.61 | 12,401 | 44.77 k | 361,764 |
| 31 Jan 24 | XERS Xeris Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 175,000 | 0.00 | 446,860 |
